 In addition, specific tumor accumulation and metabolic fate of 131-I-NM404 will be determined in NSCLC tumors collected in 5 patients part 2 - complete. Lastly, the study will collect preliminary data on imaging NSCLC tumors in up to 12 patients with evaluable disease part 3 - ongoing. 